Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 5.35090001 |
2 | translational termination (GO:0006415) | 5.06566017 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.60738010 |
4 | negative regulation of cell killing (GO:0031342) | 4.60738010 |
5 | ribosomal small subunit biogenesis (GO:0042274) | 4.29478624 |
6 | translational elongation (GO:0006414) | 4.26244048 |
7 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.16964583 |
8 | response to peptidoglycan (GO:0032494) | 4.01849650 |
9 | viral life cycle (GO:0019058) | 4.01478367 |
10 | ribosomal small subunit assembly (GO:0000028) | 3.96090074 |
11 | mannose metabolic process (GO:0006013) | 3.95844518 |
12 | maturation of SSU-rRNA (GO:0030490) | 3.84593331 |
13 | translational initiation (GO:0006413) | 3.83585038 |
14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.81124974 |
15 | cellular protein complex disassembly (GO:0043624) | 3.80224825 |
16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.79968040 |
17 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.78852553 |
18 | protein targeting to ER (GO:0045047) | 3.75397348 |
19 | cotranslational protein targeting to membrane (GO:0006613) | 3.71701660 |
20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.66445293 |
21 | NIK/NF-kappaB signaling (GO:0038061) | 3.61436576 |
22 | negative regulation of RNA splicing (GO:0033119) | 3.59841313 |
23 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.56845794 |
24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.53037960 |
25 | modulation by symbiont of host defense response (GO:0052031) | 3.53037960 |
26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.53037960 |
27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.53037960 |
28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52132125 |
29 | protein complex disassembly (GO:0043241) | 3.52008785 |
30 | protein localization to endoplasmic reticulum (GO:0070972) | 3.45225795 |
31 | DNA unwinding involved in DNA replication (GO:0006268) | 3.39320680 |
32 | negative regulation of mRNA processing (GO:0050686) | 3.39158986 |
33 | positive thymic T cell selection (GO:0045059) | 3.38537615 |
34 | B cell receptor signaling pathway (GO:0050853) | 3.38038381 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.33045340 |
36 | germinal center formation (GO:0002467) | 3.29685004 |
37 | macrophage activation involved in immune response (GO:0002281) | 3.28183579 |
38 | protein localization to endosome (GO:0036010) | 3.27213934 |
39 | macromolecular complex disassembly (GO:0032984) | 3.24369081 |
40 | ribosomal large subunit biogenesis (GO:0042273) | 3.24245250 |
41 | activation of MAPKKK activity (GO:0000185) | 3.19831210 |
42 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16413893 |
43 | detection of other organism (GO:0098543) | 3.12488167 |
44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08783762 |
45 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.08555640 |
46 | detection of bacterium (GO:0016045) | 3.04597980 |
47 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.02902247 |
48 | negative regulation of mRNA metabolic process (GO:1903312) | 3.01912138 |
49 | heterochromatin organization (GO:0070828) | 3.00198274 |
50 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.00185443 |
51 | modulation by symbiont of host cellular process (GO:0044068) | 2.96457209 |
52 | negative regulation of phagocytosis (GO:0050765) | 2.94623124 |
53 | neutrophil activation involved in immune response (GO:0002283) | 2.94234163 |
54 | positive regulation of Rap GTPase activity (GO:0032854) | 2.93780667 |
55 | leukocyte aggregation (GO:0070486) | 2.93213932 |
56 | mRNA catabolic process (GO:0006402) | 2.91039067 |
57 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90616136 |
58 | regulation of leukocyte degranulation (GO:0043300) | 2.87990257 |
59 | RNA catabolic process (GO:0006401) | 2.84675993 |
60 | pinocytosis (GO:0006907) | 2.84572523 |
61 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.83581114 |
62 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.81343061 |
63 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.76160921 |
64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.75987578 |
65 | regulation of B cell differentiation (GO:0045577) | 2.75836831 |
66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74145298 |
67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.74145298 |
68 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.72105123 |
69 | type I interferon signaling pathway (GO:0060337) | 2.71913819 |
70 | cellular response to type I interferon (GO:0071357) | 2.71913819 |
71 | response to type I interferon (GO:0034340) | 2.71877818 |
72 | protein localization to kinetochore (GO:0034501) | 2.71677730 |
73 | barbed-end actin filament capping (GO:0051016) | 2.71025939 |
74 | DNA replication initiation (GO:0006270) | 2.70334527 |
75 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.69136571 |
76 | mature B cell differentiation (GO:0002335) | 2.68465505 |
77 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.68183622 |
78 | stress fiber assembly (GO:0043149) | 2.67489171 |
79 | regulation of monocyte differentiation (GO:0045655) | 2.67109870 |
80 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66216299 |
81 | thymic T cell selection (GO:0045061) | 2.64317716 |
82 | modulation by virus of host process (GO:0019054) | 2.61957048 |
83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.61126598 |
84 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.61031034 |
85 | regulation of ARF protein signal transduction (GO:0032012) | 2.59213464 |
86 | DNA strand elongation (GO:0022616) | 2.59167715 |
87 | positive regulation of lamellipodium assembly (GO:0010592) | 2.58988942 |
88 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.57438957 |
89 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.56320721 |
90 | actin nucleation (GO:0045010) | 2.56106574 |
91 | RNA stabilization (GO:0043489) | 2.56028685 |
92 | mRNA stabilization (GO:0048255) | 2.56028685 |
93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.54220657 |
94 | regulation of mast cell degranulation (GO:0043304) | 2.53592327 |
95 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53474211 |
96 | positive regulation of protein homooligomerization (GO:0032464) | 2.52903934 |
97 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.51918666 |
98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51605183 |
99 | protein targeting to membrane (GO:0006612) | 2.51503000 |
100 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.51494835 |
101 | positive regulation of B cell differentiation (GO:0045579) | 2.51331455 |
102 | positive T cell selection (GO:0043368) | 2.51065526 |
103 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.50891845 |
104 | detection of external biotic stimulus (GO:0098581) | 2.50831535 |
105 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50458032 |
106 | cellular response to zinc ion (GO:0071294) | 2.50380115 |
107 | ncRNA 3-end processing (GO:0043628) | 2.49856878 |
108 | termination of RNA polymerase II transcription (GO:0006369) | 2.49637606 |
109 | immunoglobulin mediated immune response (GO:0016064) | 2.49439021 |
110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49005399 |
111 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.48576658 |
112 | response to muramyl dipeptide (GO:0032495) | 2.47985114 |
113 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.46378240 |
114 | protein localization to chromosome, centromeric region (GO:0071459) | 2.45472781 |
115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.45398040 |
116 | cellular extravasation (GO:0045123) | 2.45098450 |
117 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.43956969 |
118 | B cell mediated immunity (GO:0019724) | 2.43479603 |
119 | regulation of superoxide anion generation (GO:0032928) | 2.43228718 |
120 | glycosphingolipid catabolic process (GO:0046479) | 2.42241392 |
121 | negative regulation of interleukin-12 production (GO:0032695) | 2.41852781 |
122 | formation of translation preinitiation complex (GO:0001731) | 2.40906956 |
123 | regulation of macrophage cytokine production (GO:0010935) | 2.40261815 |
124 | negative regulation of innate immune response (GO:0045824) | 2.39901057 |
125 | regulation of necroptotic process (GO:0060544) | 2.39612652 |
126 | myeloid dendritic cell differentiation (GO:0043011) | 2.39422646 |
127 | positive regulation of protein dephosphorylation (GO:0035307) | 2.39318287 |
128 | response to protozoan (GO:0001562) | 2.39304006 |
129 | regulation of protein heterodimerization activity (GO:0043497) | 2.37563409 |
130 | signal complex assembly (GO:0007172) | 2.37039377 |
131 | defense response to protozoan (GO:0042832) | 2.36538283 |
132 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.34995404 |
133 | negative regulation of histone methylation (GO:0031061) | 2.34948298 |
134 | negative thymic T cell selection (GO:0045060) | 2.34747865 |
135 | DNA replication checkpoint (GO:0000076) | 2.34375085 |
136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.32817445 |
137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.32548923 |
138 | T cell homeostasis (GO:0043029) | 2.31933899 |
139 | negative regulation of granulocyte differentiation (GO:0030853) | 2.31929358 |
140 | negative T cell selection (GO:0043383) | 2.31582627 |
141 | pentose-phosphate shunt (GO:0006098) | 2.31576557 |
142 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.31439893 |
143 | negative regulation of type 2 immune response (GO:0002829) | 2.31385958 |
144 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.31356411 |
145 | regulation of regulated secretory pathway (GO:1903305) | 2.31250488 |
146 | respiratory burst (GO:0045730) | 2.30414021 |
147 | activation of JUN kinase activity (GO:0007257) | 2.30100937 |
148 | response to laminar fluid shear stress (GO:0034616) | 2.30077001 |
149 | natural killer cell differentiation (GO:0001779) | 2.29367771 |
150 | mature B cell differentiation involved in immune response (GO:0002313) | 2.29140352 |
151 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.29046044 |
152 | T cell selection (GO:0045058) | 2.28864254 |
153 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28400148 |
154 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.28300093 |
155 | positive regulation of mast cell activation (GO:0033005) | 2.28045864 |
156 | dosage compensation (GO:0007549) | 2.27628676 |
157 | regulation of histone H3-K9 methylation (GO:0051570) | 2.27105862 |
158 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.26808963 |
159 | adenosine receptor signaling pathway (GO:0001973) | 2.26399176 |
160 | regulation of necrotic cell death (GO:0010939) | 2.26394218 |
161 | macrophage activation (GO:0042116) | 2.26369074 |
162 | embryonic process involved in female pregnancy (GO:0060136) | 2.26356134 |
163 | T cell apoptotic process (GO:0070231) | 2.26166791 |
164 | regulation of lipid kinase activity (GO:0043550) | 2.26085330 |
165 | regulation of early endosome to late endosome transport (GO:2000641) | 2.25749089 |
166 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.25727203 |
167 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.25573460 |
168 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.23861635 |
169 | regulation of erythrocyte differentiation (GO:0045646) | 2.23132170 |
170 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.21517781 |
171 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.20891721 |
172 | megakaryocyte development (GO:0035855) | 2.20321732 |
173 | rRNA processing (GO:0006364) | 2.19839581 |
174 | modulation by symbiont of host immune response (GO:0052553) | 2.19202958 |
175 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.19202958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.81503223 |
2 | MYC_22102868_ChIP-Seq_BL_Human | 3.71282604 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.68682870 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.60739176 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.35675053 |
6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.78646334 |
7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.64771843 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.56002419 |
9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41988609 |
10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.32377137 |
11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.27824902 |
12 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.25986934 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21329736 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.18765691 |
15 | * MAF_26560356_Chip-Seq_TH1_Human | 2.11672986 |
16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05140679 |
17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04125899 |
18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01504992 |
19 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98448419 |
20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.97652709 |
21 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.97435390 |
22 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.97073550 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93163567 |
24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92679197 |
25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.92607010 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.91337754 |
27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.85597838 |
28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.84332372 |
29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80133940 |
30 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78944635 |
31 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.78615862 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75181344 |
33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.74692494 |
34 | KDM2B_26808549_Chip-Seq_K562_Human | 1.74236376 |
35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72079298 |
36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71516576 |
37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.70740958 |
38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70117041 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69273745 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68777648 |
41 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68077786 |
42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.66190576 |
43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65824507 |
44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62673403 |
45 | * MYB_26560356_Chip-Seq_TH1_Human | 1.62425110 |
46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61823171 |
47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60919144 |
48 | MYB_26560356_Chip-Seq_TH2_Human | 1.58701400 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.58360354 |
50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53503469 |
51 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53298636 |
52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51365133 |
53 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51239796 |
54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50822417 |
55 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50816800 |
56 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48506131 |
57 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.48304002 |
58 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.48304002 |
59 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.48304002 |
60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46952750 |
61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45964798 |
62 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41922447 |
63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39249203 |
64 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39094276 |
65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37889947 |
66 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37784851 |
67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.36492813 |
68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.36460190 |
69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35048465 |
70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34089980 |
71 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32061671 |
72 | * P68_20966046_ChIP-Seq_HELA_Human | 1.31384498 |
73 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31125478 |
74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30977596 |
75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30771457 |
76 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.30430576 |
77 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30119344 |
78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30069164 |
79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29533452 |
80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28054715 |
81 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27440474 |
82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26729509 |
83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26546975 |
84 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25893244 |
85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24909868 |
86 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.22443708 |
87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22212943 |
88 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22158371 |
89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21030814 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19955713 |
91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19622783 |
92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19456126 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19308829 |
94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19066143 |
95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18752753 |
96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18638142 |
97 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16679252 |
98 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16544440 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15177176 |
100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13634258 |
101 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13218054 |
102 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12984170 |
103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11952906 |
104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11811130 |
105 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11599742 |
106 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11410998 |
107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11386146 |
108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10764556 |
109 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09422776 |
110 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08715261 |
111 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08454016 |
112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08095076 |
113 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07601367 |
114 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07388415 |
115 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05984960 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05814161 |
117 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05793138 |
118 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05543786 |
119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04627544 |
120 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03854712 |
121 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03577932 |
122 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03078828 |
123 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02751305 |
124 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02129537 |
125 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01772049 |
126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01225057 |
127 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01003169 |
128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00397611 |
129 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99390710 |
130 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98091465 |
131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97901460 |
132 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97836856 |
133 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97145641 |
134 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.96208750 |
135 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95033562 |
136 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94706869 |
137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94229917 |
138 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93418895 |
139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90244667 |
140 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89564809 |
141 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89360484 |
142 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88656595 |
143 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.87975245 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.12509309 |
2 | MP0009278_abnormal_bone_marrow | 3.31713496 |
3 | MP0005058_abnormal_lysosome_morphology | 3.31180834 |
4 | MP0003172_abnormal_lysosome_physiology | 2.71438372 |
5 | MP0000685_abnormal_immune_system | 2.58413121 |
6 | MP0008260_abnormal_autophagy | 2.54402650 |
7 | MP0009840_abnormal_foam_cell | 2.47431814 |
8 | MP0001800_abnormal_humoral_immune | 2.42207551 |
9 | MP0008057_abnormal_DNA_replication | 2.40212704 |
10 | MP0005397_hematopoietic_system_phenotyp | 2.30500329 |
11 | MP0001545_abnormal_hematopoietic_system | 2.30500329 |
12 | MP0005451_abnormal_body_composition | 2.29854789 |
13 | MP0005174_abnormal_tail_pigmentation | 2.29581155 |
14 | MP0003763_abnormal_thymus_physiology | 2.26758331 |
15 | MP0009379_abnormal_foot_pigmentation | 2.26698627 |
16 | MP0002396_abnormal_hematopoietic_system | 2.23422956 |
17 | MP0003436_decreased_susceptibility_to | 2.22966401 |
18 | MP0003693_abnormal_embryo_hatching | 2.21725059 |
19 | MP0003111_abnormal_nucleus_morphology | 2.21636228 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.20816136 |
21 | MP0002398_abnormal_bone_marrow | 2.16552619 |
22 | MP0002452_abnormal_antigen_presenting | 2.16182846 |
23 | MP0004808_abnormal_hematopoietic_stem | 2.10291001 |
24 | MP0002420_abnormal_adaptive_immunity | 2.05760454 |
25 | MP0001790_abnormal_immune_system | 2.05100299 |
26 | MP0005387_immune_system_phenotype | 2.05100299 |
27 | MP0001819_abnormal_immune_cell | 2.03313326 |
28 | MP0004957_abnormal_blastocyst_morpholog | 2.01960129 |
29 | MP0010094_abnormal_chromosome_stability | 2.00410709 |
30 | MP0001835_abnormal_antigen_presentation | 1.97275041 |
31 | MP0005000_abnormal_immune_tolerance | 1.96706027 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.95914411 |
33 | MP0002723_abnormal_immune_serum | 1.95389193 |
34 | MP0005076_abnormal_cell_differentiation | 1.91386718 |
35 | MP0000689_abnormal_spleen_morphology | 1.82643975 |
36 | MP0003300_gastrointestinal_ulcer | 1.82396398 |
37 | MP0001849_ear_inflammation | 1.81697859 |
38 | MP0000490_abnormal_crypts_of | 1.81107046 |
39 | MP0005671_abnormal_response_to | 1.79958539 |
40 | MP0002405_respiratory_system_inflammati | 1.78743266 |
41 | MP0003077_abnormal_cell_cycle | 1.77511789 |
42 | MP0000716_abnormal_immune_system | 1.76208515 |
43 | MP0002722_abnormal_immune_system | 1.75197183 |
44 | MP0000703_abnormal_thymus_morphology | 1.74798903 |
45 | MP0005025_abnormal_response_to | 1.73253868 |
46 | MP0003091_abnormal_cell_migration | 1.71437928 |
47 | MP0003329_amyloid_beta_deposits | 1.62841131 |
48 | MP0002419_abnormal_innate_immunity | 1.60295293 |
49 | MP0000604_amyloidosis | 1.60282434 |
50 | MP0002429_abnormal_blood_cell | 1.56466475 |
51 | MP0005464_abnormal_platelet_physiology | 1.52394773 |
52 | MP0009785_altered_susceptibility_to | 1.51885547 |
53 | MP0010352_gastrointestinal_tract_polyps | 1.49191555 |
54 | MP0001873_stomach_inflammation | 1.47103630 |
55 | MP0002148_abnormal_hypersensitivity_rea | 1.45546967 |
56 | MP0001853_heart_inflammation | 1.44581120 |
57 | MP0003448_altered_tumor_morphology | 1.44132440 |
58 | MP0002998_abnormal_bone_remodeling | 1.43687406 |
59 | MP0010307_abnormal_tumor_latency | 1.43530763 |
60 | MP0003690_abnormal_glial_cell | 1.41186898 |
61 | MP0003724_increased_susceptibility_to | 1.40290893 |
62 | MP0000858_altered_metastatic_potential | 1.39559983 |
63 | MP0008007_abnormal_cellular_replicative | 1.37780251 |
64 | MP0010155_abnormal_intestine_physiology | 1.34893531 |
65 | MP0005666_abnormal_adipose_tissue | 1.34690992 |
66 | MP0003866_abnormal_defecation | 1.33597551 |
67 | MP0000350_abnormal_cell_proliferation | 1.32025321 |
68 | MP0002019_abnormal_tumor_incidence | 1.27250736 |
69 | MP0004510_myositis | 1.24060407 |
70 | MP0004947_skin_inflammation | 1.22264915 |
71 | MP0002166_altered_tumor_susceptibility | 1.19086920 |
72 | MP0005409_darkened_coat_color | 1.18536488 |
73 | MP0001730_embryonic_growth_arrest | 1.17105149 |
74 | MP0002138_abnormal_hepatobiliary_system | 1.15118941 |
75 | MP0003453_abnormal_keratinocyte_physiol | 1.14876639 |
76 | MP0003566_abnormal_cell_adhesion | 1.11837868 |
77 | MP0006082_CNS_inflammation | 1.11762237 |
78 | MP0005166_decreased_susceptibility_to | 1.08373997 |
79 | MP0000465_gastrointestinal_hemorrhage | 1.07612386 |
80 | MP0001845_abnormal_inflammatory_respons | 1.06240828 |
81 | MP0003279_aneurysm | 1.06005259 |
82 | MP0005375_adipose_tissue_phenotype | 1.04136753 |
83 | MP0008469_abnormal_protein_level | 1.03259117 |
84 | MP0004185_abnormal_adipocyte_glucose | 1.02263079 |
85 | MP0002006_tumorigenesis | 0.99538428 |
86 | MP0002933_joint_inflammation | 0.99014856 |
87 | MP0000313_abnormal_cell_death | 0.97018594 |
88 | MP0003828_pulmonary_edema | 0.96993716 |
89 | MP0000343_altered_response_to | 0.95562301 |
90 | MP0001851_eye_inflammation | 0.95514586 |
91 | MP0008874_decreased_physiological_sensi | 0.93280469 |
92 | MP0002254_reproductive_system_inflammat | 0.92922172 |
93 | MP0005023_abnormal_wound_healing | 0.92746384 |
94 | MP0005310_abnormal_salivary_gland | 0.91850318 |
95 | MP0003183_abnormal_peptide_metabolism | 0.91809927 |
96 | MP0002877_abnormal_melanocyte_morpholog | 0.90553275 |
97 | MP0005390_skeleton_phenotype | 0.89958872 |
98 | MP0003656_abnormal_erythrocyte_physiolo | 0.89258477 |
99 | MP0008058_abnormal_DNA_repair | 0.88466612 |
100 | MP0002086_abnormal_extraembryonic_tissu | 0.88449335 |
101 | MP0000015_abnormal_ear_pigmentation | 0.87644493 |
102 | MP0001533_abnormal_skeleton_physiology | 0.87109410 |
103 | MP0005621_abnormal_cell_physiology | 0.86834981 |
104 | MP0005501_abnormal_skin_physiology | 0.84888030 |
105 | MP0005167_abnormal_blood-brain_barrier | 0.84827806 |
106 | MP0005165_increased_susceptibility_to | 0.84674501 |
107 | MP0000767_abnormal_smooth_muscle | 0.83201877 |
108 | MP0002080_prenatal_lethality | 0.81834054 |
109 | MP0008995_early_reproductive_senescence | 0.81705252 |
110 | MP0000249_abnormal_blood_vessel | 0.80318380 |
111 | MP0008004_abnormal_stomach_pH | 0.79405888 |
112 | MP0008932_abnormal_embryonic_tissue | 0.78373226 |
113 | MP0001697_abnormal_embryo_size | 0.78066946 |
114 | MP0002085_abnormal_embryonic_tissue | 0.75317087 |
115 | MP0008877_abnormal_DNA_methylation | 0.74666203 |
116 | MP0002796_impaired_skin_barrier | 0.73882672 |
117 | MP0002084_abnormal_developmental_patter | 0.72268705 |
118 | MP0009764_decreased_sensitivity_to | 0.71690761 |
119 | MP0000477_abnormal_intestine_morphology | 0.71465810 |
120 | MP0004858_abnormal_nervous_system | 0.70992055 |
121 | MP0003075_altered_response_to | 0.70193547 |
122 | MP0008770_decreased_survivor_rate | 0.69723481 |
123 | MP0005380_embryogenesis_phenotype | 0.69526790 |
124 | MP0001672_abnormal_embryogenesis/_devel | 0.69526790 |
125 | MP0000003_abnormal_adipose_tissue | 0.69520252 |
126 | MP0005164_abnormal_response_to | 0.68880866 |
127 | MP0000920_abnormal_myelination | 0.68106389 |
128 | MP0003795_abnormal_bone_structure | 0.67463099 |
129 | MP0003705_abnormal_hypodermis_morpholog | 0.67417651 |
130 | MP0002089_abnormal_postnatal_growth/wei | 0.67283222 |
131 | MP0004197_abnormal_fetal_growth/weight/ | 0.67049254 |
132 | MP0003786_premature_aging | 0.66019799 |
133 | MP0003123_paternal_imprinting | 0.65930917 |
134 | MP0003984_embryonic_growth_retardation | 0.64792616 |
135 | MP0003634_abnormal_glial_cell | 0.64408732 |
136 | MP0002088_abnormal_embryonic_growth/wei | 0.63390492 |
137 | MP0001663_abnormal_digestive_system | 0.62271259 |
138 | MP0003136_yellow_coat_color | 0.62228893 |
139 | MP0009931_abnormal_skin_appearance | 0.62103077 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Reticulocytopenia (HP:0001896) | 3.92626656 |
2 | Recurrent abscess formation (HP:0002722) | 3.79445377 |
3 | Cellulitis (HP:0100658) | 3.60257443 |
4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.54112344 |
5 | Eczematoid dermatitis (HP:0000976) | 3.50195912 |
6 | Obstructive lung disease (HP:0006536) | 3.43013544 |
7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.43013544 |
8 | Abnormal number of erythroid precursors (HP:0012131) | 3.25247058 |
9 | Recurrent fungal infections (HP:0002841) | 3.24706651 |
10 | Dysostosis multiplex (HP:0000943) | 3.24337815 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.10498367 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.10498367 |
13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.10498367 |
14 | Recurrent bacterial skin infections (HP:0005406) | 3.05912559 |
15 | Mediastinal lymphadenopathy (HP:0100721) | 3.03537376 |
16 | Polygenic inheritance (HP:0010982) | 3.01835919 |
17 | Spontaneous hematomas (HP:0007420) | 2.92565828 |
18 | Recurrent viral infections (HP:0004429) | 2.91382410 |
19 | Hematochezia (HP:0002573) | 2.91191247 |
20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.90451265 |
21 | Loss of speech (HP:0002371) | 2.79779877 |
22 | Gastrointestinal inflammation (HP:0004386) | 2.79385506 |
23 | Chronic otitis media (HP:0000389) | 2.77712080 |
24 | Pustule (HP:0200039) | 2.77537535 |
25 | Inflammation of the large intestine (HP:0002037) | 2.74017203 |
26 | Pallor (HP:0000980) | 2.73746699 |
27 | Abnormality of the nasal mucosa (HP:0000433) | 2.71046104 |
28 | Obstructive sleep apnea (HP:0002870) | 2.69249672 |
29 | Increased IgE level (HP:0003212) | 2.65090889 |
30 | Neurofibrillary tangles (HP:0002185) | 2.64650454 |
31 | Systemic lupus erythematosus (HP:0002725) | 2.64322951 |
32 | Panhypogammaglobulinemia (HP:0003139) | 2.62102555 |
33 | Meningitis (HP:0001287) | 2.61925318 |
34 | Nasal polyposis (HP:0100582) | 2.59435677 |
35 | Nuclear cataract (HP:0100018) | 2.55924158 |
36 | Colitis (HP:0002583) | 2.52093165 |
37 | Basal cell carcinoma (HP:0002671) | 2.51073700 |
38 | Broad face (HP:0000283) | 2.48412352 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44834645 |
40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44834645 |
41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44235581 |
42 | Stomatitis (HP:0010280) | 2.40881247 |
43 | Neuronal loss in central nervous system (HP:0002529) | 2.40508296 |
44 | Agammaglobulinemia (HP:0004432) | 2.38942691 |
45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38566190 |
46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38566190 |
47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38566190 |
48 | Selective tooth agenesis (HP:0001592) | 2.38201380 |
49 | Thrombocytosis (HP:0001894) | 2.36300452 |
50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35571985 |
51 | Mucopolysacchariduria (HP:0008155) | 2.35571985 |
52 | Cerebral inclusion bodies (HP:0100314) | 2.34712537 |
53 | Gastrointestinal stroma tumor (HP:0100723) | 2.34559252 |
54 | Prolonged bleeding time (HP:0003010) | 2.32064184 |
55 | Macrocytic anemia (HP:0001972) | 2.31719458 |
56 | IgM deficiency (HP:0002850) | 2.30954484 |
57 | Absent thumb (HP:0009777) | 2.28611076 |
58 | Distal lower limb amyotrophy (HP:0008944) | 2.27440384 |
59 | Fatigue (HP:0012378) | 2.27214685 |
60 | Papilloma (HP:0012740) | 2.26834624 |
61 | Verrucae (HP:0200043) | 2.26834624 |
62 | Supranuclear gaze palsy (HP:0000605) | 2.26330782 |
63 | Thin bony cortex (HP:0002753) | 2.24069187 |
64 | Vertebral compression fractures (HP:0002953) | 2.21441594 |
65 | Hypochromic anemia (HP:0001931) | 2.21430414 |
66 | Orchitis (HP:0100796) | 2.19560121 |
67 | Myocardial infarction (HP:0001658) | 2.16758632 |
68 | Amyloidosis (HP:0011034) | 2.15886548 |
69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.14423935 |
70 | Recurrent skin infections (HP:0001581) | 2.12109251 |
71 | T lymphocytopenia (HP:0005403) | 2.11002719 |
72 | Cerebral aneurysm (HP:0004944) | 2.08147426 |
73 | Abnormality of T cells (HP:0002843) | 2.07329942 |
74 | Abnormality of T cell number (HP:0011839) | 2.07088836 |
75 | Abnormality of the thoracic spine (HP:0100711) | 2.07071525 |
76 | Recurrent bronchitis (HP:0002837) | 2.06895752 |
77 | Slow saccadic eye movements (HP:0000514) | 2.05316387 |
78 | Abnormality of the fingertips (HP:0001211) | 2.03565667 |
79 | Chronic sinusitis (HP:0011109) | 2.03445938 |
80 | Annular pancreas (HP:0001734) | 2.02053721 |
81 | Long palpebral fissure (HP:0000637) | 2.01623294 |
82 | Thoracic kyphosis (HP:0002942) | 2.01069319 |
83 | Purpura (HP:0000979) | 2.00621151 |
84 | Distal lower limb muscle weakness (HP:0009053) | 2.00408233 |
85 | Myositis (HP:0100614) | 1.99894223 |
86 | Peripheral hypomyelination (HP:0007182) | 1.99713205 |
87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.99474345 |
88 | Acute lymphatic leukemia (HP:0006721) | 1.97360653 |
89 | Sparse lateral eyebrow (HP:0005338) | 1.95538426 |
90 | Emphysema (HP:0002097) | 1.94976335 |
91 | Breast hypoplasia (HP:0003187) | 1.94870614 |
92 | Concave nail (HP:0001598) | 1.94477810 |
93 | Increased connective tissue (HP:0009025) | 1.91528829 |
94 | Genu recurvatum (HP:0002816) | 1.91422090 |
95 | Petechiae (HP:0000967) | 1.90828657 |
96 | Apathy (HP:0000741) | 1.90142307 |
97 | Vasculitis (HP:0002633) | 1.88820428 |
98 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.88703195 |
99 | Agnosia (HP:0010524) | 1.88394043 |
100 | Facial hemangioma (HP:0000329) | 1.87500709 |
101 | Asplenia (HP:0001746) | 1.87141052 |
102 | Increased cerebral lipofuscin (HP:0011813) | 1.86975806 |
103 | Myelodysplasia (HP:0002863) | 1.86251419 |
104 | Abnormality of T cell physiology (HP:0011840) | 1.85364032 |
105 | Hypertensive crisis (HP:0100735) | 1.85289589 |
106 | Leukocytosis (HP:0001974) | 1.84801501 |
107 | Increased serum ferritin (HP:0003281) | 1.84769769 |
108 | Increased density of long bones (HP:0006392) | 1.84195812 |
109 | Vacuolated lymphocytes (HP:0001922) | 1.82928764 |
110 | Abnormality of macrophages (HP:0004311) | 1.81323180 |
111 | Lymphoma (HP:0002665) | 1.81205325 |
112 | Difficulty climbing stairs (HP:0003551) | 1.80927887 |
113 | Thyroiditis (HP:0100646) | 1.80248637 |
114 | Hepatosplenomegaly (HP:0001433) | 1.79472487 |
115 | Lymphopenia (HP:0001888) | 1.79464138 |
116 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.79244215 |
117 | Axonal loss (HP:0003447) | 1.78721514 |
118 | Restrictive lung disease (HP:0002091) | 1.78136758 |
119 | Lower limb amyotrophy (HP:0007210) | 1.77816385 |
120 | Retrobulbar optic neuritis (HP:0100654) | 1.77069247 |
121 | Optic neuritis (HP:0100653) | 1.77069247 |
122 | Interstitial pulmonary disease (HP:0006530) | 1.76855588 |
123 | Hypertriglyceridemia (HP:0002155) | 1.76177562 |
124 | Abnormality of complement system (HP:0005339) | 1.75476294 |
125 | Hyperacusis (HP:0010780) | 1.74660133 |
126 | Esophageal varix (HP:0002040) | 1.74653175 |
127 | Urticaria (HP:0001025) | 1.73819204 |
128 | Polycythemia (HP:0001901) | 1.73460685 |
129 | Gingivitis (HP:0000230) | 1.72462168 |
130 | Hypergammaglobulinemia (HP:0010702) | 1.71557610 |
131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.71091656 |
132 | Epistaxis (HP:0000421) | 1.70929250 |
133 | Cervical subluxation (HP:0003308) | 1.70813797 |
134 | Osteomyelitis (HP:0002754) | 1.70789650 |
135 | High pitched voice (HP:0001620) | 1.70701067 |
136 | Upper motor neuron abnormality (HP:0002127) | 1.70238984 |
137 | Impaired platelet aggregation (HP:0003540) | 1.70043313 |
138 | Abnormal platelet function (HP:0011869) | 1.70043313 |
139 | Cheilitis (HP:0100825) | 1.68863168 |
140 | Deep palmar crease (HP:0006191) | 1.68749565 |
141 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.68012675 |
142 | Protrusio acetabuli (HP:0003179) | 1.67684687 |
143 | Achilles tendon contracture (HP:0001771) | 1.66659614 |
144 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66403411 |
145 | Abnormality of DNA repair (HP:0003254) | 1.65740187 |
146 | Autoimmune thrombocytopenia (HP:0001973) | 1.64789992 |
147 | Ankle clonus (HP:0011448) | 1.64293115 |
148 | Abnormality of the columella (HP:0009929) | 1.63332271 |
149 | Eosinophilia (HP:0001880) | 1.63016933 |
150 | Distal upper limb amyotrophy (HP:0007149) | 1.61706421 |
151 | Diminished motivation (HP:0000745) | 1.61667519 |
152 | Patellar aplasia (HP:0006443) | 1.60880995 |
153 | Tracheoesophageal fistula (HP:0002575) | 1.60458908 |
154 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.60380646 |
155 | Squamous cell carcinoma (HP:0002860) | 1.60317336 |
156 | Basal ganglia calcification (HP:0002135) | 1.59310955 |
157 | Abnormal platelet volume (HP:0011876) | 1.58712928 |
158 | Porencephaly (HP:0002132) | 1.58452801 |
159 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.58362933 |
160 | Rectal prolapse (HP:0002035) | 1.57080216 |
161 | Bicuspid aortic valve (HP:0001647) | 1.56763937 |
162 | Recurrent sinusitis (HP:0011108) | 1.56355326 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K10 | 3.38438673 |
2 | MAP4K1 | 2.96761706 |
3 | EEF2K | 2.87462116 |
4 | TRIB3 | 2.84575418 |
5 | SMG1 | 2.74305257 |
6 | PKN2 | 2.57518072 |
7 | BLK | 2.55665043 |
8 | FES | 2.43887515 |
9 | RIPK1 | 2.23522641 |
10 | RIPK4 | 2.16258858 |
11 | SIK1 | 2.13978950 |
12 | GRK6 | 1.92379506 |
13 | NME2 | 1.91114755 |
14 | MAP3K11 | 1.86473668 |
15 | CSK | 1.78991515 |
16 | NEK2 | 1.78964473 |
17 | STK10 | 1.74975419 |
18 | TAOK2 | 1.74408818 |
19 | CDK12 | 1.73324755 |
20 | MAP3K14 | 1.65313546 |
21 | SIK2 | 1.64257769 |
22 | RPS6KA4 | 1.64113508 |
23 | CDC7 | 1.59064763 |
24 | MAP3K3 | 1.57559707 |
25 | ALK | 1.50642293 |
26 | TLK1 | 1.49083131 |
27 | PRKD2 | 1.46998690 |
28 | FGFR4 | 1.44463245 |
29 | FGR | 1.42159391 |
30 | MARK2 | 1.40259968 |
31 | ZAP70 | 1.39278702 |
32 | LRRK2 | 1.39169131 |
33 | BTK | 1.38981666 |
34 | MAP3K13 | 1.38001729 |
35 | CDK4 | 1.37697830 |
36 | MAP3K1 | 1.35780530 |
37 | CLK1 | 1.33949824 |
38 | HCK | 1.33431183 |
39 | DYRK3 | 1.31343964 |
40 | MAP2K3 | 1.31017212 |
41 | IRAK4 | 1.30247632 |
42 | TBK1 | 1.25883461 |
43 | SIK3 | 1.20432266 |
44 | MKNK2 | 1.13414277 |
45 | PIM1 | 1.13170291 |
46 | TAOK1 | 1.11098219 |
47 | CDK6 | 1.10527250 |
48 | CDK7 | 1.09267764 |
49 | PAK4 | 1.08622395 |
50 | TYK2 | 1.07492652 |
51 | MAP3K6 | 1.05708425 |
52 | WEE1 | 1.03614372 |
53 | RPS6KB2 | 1.02147778 |
54 | ERN1 | 1.00391687 |
55 | CDC42BPA | 1.00172240 |
56 | MAP3K8 | 0.99594731 |
57 | PIM2 | 0.98605789 |
58 | IRAK3 | 0.98027324 |
59 | LCK | 0.97878495 |
60 | BRD4 | 0.97805598 |
61 | SYK | 0.97028144 |
62 | JAK3 | 0.93297935 |
63 | PDGFRA | 0.92855077 |
64 | PTK6 | 0.91502094 |
65 | ARAF | 0.90035072 |
66 | PRPF4B | 0.89206904 |
67 | NLK | 0.89194169 |
68 | KIT | 0.86747100 |
69 | TTN | 0.85515549 |
70 | BMX | 0.80423517 |
71 | IKBKB | 0.80001060 |
72 | MAPK12 | 0.79769652 |
73 | TGFBR2 | 0.79760744 |
74 | JAK1 | 0.79673569 |
75 | TYRO3 | 0.79218191 |
76 | LYN | 0.77711452 |
77 | PDPK1 | 0.76509166 |
78 | IRAK2 | 0.76199205 |
79 | DDR2 | 0.75602268 |
80 | TEC | 0.74654421 |
81 | CDK19 | 0.73936126 |
82 | MTOR | 0.71387660 |
83 | BUB1 | 0.71384997 |
84 | ITK | 0.70433849 |
85 | MATK | 0.69192380 |
86 | KSR2 | 0.68704195 |
87 | MAPK15 | 0.68554510 |
88 | CSF1R | 0.68141558 |
89 | MELK | 0.66548010 |
90 | HIPK2 | 0.65315339 |
91 | MAPK11 | 0.64986585 |
92 | TNK2 | 0.64640567 |
93 | LATS2 | 0.61963497 |
94 | MAPKAPK3 | 0.61613911 |
95 | NTRK1 | 0.61406684 |
96 | MAP3K9 | 0.60727847 |
97 | RPS6KA2 | 0.60528081 |
98 | KDR | 0.60327148 |
99 | PDK1 | 0.59758642 |
100 | DAPK1 | 0.59540380 |
101 | MAP2K2 | 0.58755061 |
102 | STK11 | 0.57986413 |
103 | TESK1 | 0.57323123 |
104 | MARK3 | 0.56466648 |
105 | RET | 0.56139987 |
106 | MAPK7 | 0.55937888 |
107 | EIF2AK1 | 0.55460771 |
108 | PRKD3 | 0.54570126 |
109 | TESK2 | 0.54082393 |
110 | MKNK1 | 0.52029480 |
111 | TIE1 | 0.51579464 |
112 | RAF1 | 0.51529429 |
113 | IKBKE | 0.51430130 |
114 | MAPKAPK2 | 0.51289976 |
115 | MAPK4 | 0.49215664 |
116 | FGFR3 | 0.49181039 |
117 | TGFBR1 | 0.49166723 |
118 | CDK8 | 0.47775164 |
119 | MAP3K7 | 0.47519102 |
120 | CAMKK1 | 0.46500683 |
121 | EPHB1 | 0.46475452 |
122 | MOS | 0.46408003 |
123 | DMPK | 0.46067425 |
124 | ATR | 0.44477366 |
125 | YES1 | 0.43914682 |
126 | JAK2 | 0.43680528 |
127 | CDK2 | 0.42462237 |
128 | ICK | 0.41826599 |
129 | RPS6KC1 | 0.39376319 |
130 | RPS6KL1 | 0.39376319 |
131 | PLK1 | 0.37723173 |
132 | ILK | 0.36980261 |
133 | PRKD1 | 0.36950852 |
134 | SGK3 | 0.36438981 |
135 | CHEK1 | 0.36292843 |
136 | CHUK | 0.36205632 |
137 | IRAK1 | 0.35951136 |
138 | RPS6KA6 | 0.35782583 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 2.90571248 |
2 | DNA replication_Homo sapiens_hsa03030 | 2.39561043 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.23454177 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.18830775 |
5 | Spliceosome_Homo sapiens_hsa03040 | 1.96150462 |
6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92805857 |
7 | Mismatch repair_Homo sapiens_hsa03430 | 1.89964259 |
8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78505525 |
9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.77955756 |
10 | Base excision repair_Homo sapiens_hsa03410 | 1.74682446 |
11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63972021 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62214554 |
13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55018910 |
14 | Prion diseases_Homo sapiens_hsa05020 | 1.53356519 |
15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49711992 |
16 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46422771 |
17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.44404395 |
18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43067476 |
19 | Shigellosis_Homo sapiens_hsa05131 | 1.40834715 |
20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36261994 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35964156 |
22 | Lysosome_Homo sapiens_hsa04142 | 1.34173812 |
23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34107928 |
24 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32595377 |
25 | Homologous recombination_Homo sapiens_hsa03440 | 1.32215177 |
26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28149233 |
27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.25972178 |
28 | Cell cycle_Homo sapiens_hsa04110 | 1.25771310 |
29 | RNA transport_Homo sapiens_hsa03013 | 1.23709823 |
30 | Measles_Homo sapiens_hsa05162 | 1.21955867 |
31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19259659 |
32 | Allograft rejection_Homo sapiens_hsa05330 | 1.19166561 |
33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17810509 |
34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17667952 |
35 | Hepatitis B_Homo sapiens_hsa05161 | 1.16110348 |
36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.12975512 |
37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.12323326 |
38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10394028 |
39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10339734 |
40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.07323924 |
41 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04876474 |
42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04312275 |
43 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04182430 |
44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02914724 |
45 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02904738 |
46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02317379 |
47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01635281 |
48 | Tuberculosis_Homo sapiens_hsa05152 | 1.01507674 |
49 | Bladder cancer_Homo sapiens_hsa05219 | 1.00641348 |
50 | Platelet activation_Homo sapiens_hsa04611 | 0.99650403 |
51 | Amoebiasis_Homo sapiens_hsa05146 | 0.99527237 |
52 | Apoptosis_Homo sapiens_hsa04210 | 0.99420559 |
53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99038641 |
54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97192756 |
55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96653143 |
56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96250332 |
57 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95689341 |
58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95640494 |
59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95323130 |
60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94585403 |
61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94439164 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92799208 |
63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92333888 |
64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91550495 |
65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.91221057 |
66 | Legionellosis_Homo sapiens_hsa05134 | 0.90929032 |
67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90871052 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88722506 |
69 | Glioma_Homo sapiens_hsa05214 | 0.87692462 |
70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87428707 |
71 | Influenza A_Homo sapiens_hsa05164 | 0.86679597 |
72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86030935 |
73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84558236 |
74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83785629 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83629326 |
76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82914181 |
77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82814263 |
78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82585586 |
79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82296317 |
80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81826655 |
81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79407595 |
82 | Pertussis_Homo sapiens_hsa05133 | 0.79112271 |
83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78023399 |
84 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77386796 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.77100969 |
86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76619549 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75690038 |
88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75499477 |
89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75218645 |
90 | Phagosome_Homo sapiens_hsa04145 | 0.74856431 |
91 | RNA polymerase_Homo sapiens_hsa03020 | 0.73547663 |
92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.73032990 |
93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72107583 |
94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71032058 |
95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70784231 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70065363 |
97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68975329 |
98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68797230 |
99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68082557 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67438086 |
101 | Asthma_Homo sapiens_hsa05310 | 0.66528945 |
102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64416159 |
103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63889467 |
104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63597751 |
105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62846811 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62436833 |
107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62176655 |
108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61926921 |
109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61762374 |
110 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61699396 |
111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61187812 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60920979 |
113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60465196 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59440784 |
115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59139018 |
116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58438694 |
117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58384178 |
118 | Insulin resistance_Homo sapiens_hsa04931 | 0.58333088 |
119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57915565 |
120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57721474 |
121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57597163 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57280027 |
123 | Long-term depression_Homo sapiens_hsa04730 | 0.57103012 |
124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56787372 |
125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55825921 |
126 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55433385 |
127 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55406186 |
128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55222144 |
129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54848002 |
130 | Prostate cancer_Homo sapiens_hsa05215 | 0.53955022 |
131 | Hepatitis C_Homo sapiens_hsa05160 | 0.52290979 |
132 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51511655 |
133 | Endocytosis_Homo sapiens_hsa04144 | 0.51392956 |
134 | Malaria_Homo sapiens_hsa05144 | 0.51092300 |
135 | Adherens junction_Homo sapiens_hsa04520 | 0.50860992 |